FindTrial
Sign In

Intravenous Midazolam Premedication to attenuate Pre-anesthesia Hypertension in Patients Undergoing Elective Surgery: a Prospective Clinical Study

Intravenous Midazolam Premedication to attenuate Pre-anesthesia Hypertension in Patients Undergoing Elective Surgery: a Prospective Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018442
Enrollment
Unknown
Registered
2018-09-18
Start date
2015-12-01
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

normortensive group:midazolam 2mg iv,preanesthesia
hypertension group:midazolam 2mg iv,preanesthesia

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 69 Years

Inclusion criteria

Inclusion criteria: Adult patients of American Society of Anesthesiologists physical status I-II, aged 18-70 years and scheduled for elective surgery of the abdomen and limbs

Exclusion criteria

Exclusion criteria: 1. Patients with midazolam contraindication; 2. Patients with severe cardiovascular and other systemic complications; 3. Excessive emaciation or overweight patients; 4. Patients with mental disorders; 5. Patients who used sedatives after admission.

Design outcomes

Primary

MeasureTime frame
blood pressure;—

Secondary

MeasureTime frame
heart rate;—

Countries

China

Contacts

Public ContactLing Tan

West China Hospital, Sichuan University

tl568786730@qq.com+86 18980601546

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026